Loading...
Remedent, Inc.
REMI•PNK
Healthcare
Medical - Instruments & Supplies
$0.01
$0.00(0.00%)
Remedent, Inc. (REMI) Financial Performance & Income Statement Overview
Review Remedent, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
14.17%
↑ 14.17%
Operating Income Growth
56.58%
↑ 56.58%
Net Income Growth
81.64%
↑ 81.64%
Operating Cash Flow Growth
-145.91%
↓ 145.91%
Operating Margin
-15.37%
↓ 15.37%
Gross Margin
64.79%
↑ 64.79%
Net Profit Margin
-31.40%
↓ 31.40%
ROE
-7.61%
↓ 7.61%
ROIC
-3.66%
↓ 3.66%
Remedent, Inc. (REMI) Income Statement & Financial Overview
Review Remedent, Inc.'s (REMI) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $253932.00 | $329831.00 | $185244.00 | $217213.00 |
| Cost of Revenue | $92322.00 | $113239.00 | $77502.00 | $99917.00 |
| Gross Profit | $161610.00 | $216592.00 | $107742.00 | $117296.00 |
| Gross Profit Ratio | $0.64 | $0.66 | $0.58 | $0.54 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $152.00 |
| SG&A Expenses | $285736.00 | $182194.00 | $115873.00 | $142179.00 |
| Operating Expenses | $285736.00 | $182194.00 | $115873.00 | $142331.00 |
| Total Costs & Expenses | $378058.00 | $295433.00 | $193375.00 | $242248.00 |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $898.00 | $650.00 | $843.00 |
| Depreciation & Amortization | $3922.00 | $4057.00 | $5436.00 | $6246.00 |
| EBITDA | -$204535.00 | $58070.00 | -$30110.00 | -$36269.00 |
| EBITDA Ratio | -$0.81 | $0.12 | -$0.01 | -$0.09 |
| Operating Income | -$124126.00 | $34400.00 | -$8130.00 | -$25040.00 |
| Operating Income Ratio | -$0.49 | $0.10 | -$0.04 | -$0.12 |
| Other Income/Expenses (Net) | -$84331.00 | $18713.00 | -$28063.00 | -$18321.00 |
| Income Before Tax | -$208457.00 | $53111.00 | -$36194.00 | -$43356.00 |
| Income Before Tax Ratio | -$0.82 | $0.16 | -$0.20 | -$0.20 |
| Income Tax Expense | $561.00 | $16044.00 | -$6682.00 | $18285.00 |
| Net Income | -$219340.00 | $36039.00 | -$29508.00 | -$61637.00 |
| Net Income Ratio | -$0.86 | $0.11 | -$0.16 | -$0.28 |
| EPS | -$0.01 | $0.002 | -$0.002 | -$0.003 |
| Diluted EPS | -$0.01 | $0.002 | -$0.002 | -$0.003 |
| Weighted Avg Shares Outstanding | $20.00M | $20.00M | $20.00M | $20.00M |
| Weighted Avg Shares Outstanding (Diluted) | $20.00M | $20.00M | $20.00M | $20.00M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan